In re Loestrin 24 Fe Antitrust Litig., No. 13-2472 (D.R.I.)
In the Loestrin case, Faruqi & Faruqi represents a pharmaceutical wholesaler and a proposed class of direct purchasers of Warner Chilcott’s oral contraceptive drug, Loestrin 24 Fe. The class alleges that Warner Chilcott and would-be generic competitors entered into a “pay for delay” conspiracy, to prevent purchasers from benefitting from lower-priced generic competition. Faruqi & Faruqi was appointed by the Court as co-lead counsel.
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.
1617 JFK Boulevard, Suite 1550
19103 Philadelphia, Pennsylvania
Neill W. Clarknclark@faruqilaw.comPhone (215) 277-5770Fax (215) 277-5771
Joseph T. Lukensjlukens@faruqilaw.comPhone (215) 277-5770Fax (215) 277-5771
Peter Kohnpkohn@faruqilaw.comPhone (215) 277-5770Fax (215) 277-5771
Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
685 Third Avenue 26th Floor New York, New York10017 (212) 983-9330 (877) 247-4292 (212) 983-9331
10866 Wilshire Boulevard Suite 1470 Los Angeles, California90024 (424) 256-2884 (424) 256-2885